Tafamidis in octogenarians with wild-type transthyretin cardiac amyloidosis: an international cohort study
Real-world tafamidis treatment improves survival without age affecting treatment efficacy, although mortality remains considerable in octogenarians.
Authors
- Sander Trenson (ORCID: https://orcid.org/0000-0002-3902-0047)
- Emma Christiaen (ORCID: https://orcid.org/0000-0002-3171-1425)
- Philippe Debonnaire (ORCID: https://orcid.org/0000-0003-1196-3016)
- Alexandre Bohyn (ORCID: https://orcid.org/0000-0001-9776-7467)
- Kris Bogaerts (ORCID: https://orcid.org/0000-0003-0188-8665)
- Anne–Catherine Pouleur (ORCID: https://orcid.org/0000-0002-2395-1787)
- René Tavernier (ORCID: https://orcid.org/0000-0003-4575-5231)
- Steven Droogmans (ORCID: https://orcid.org/0000-0003-3985-3249)
- Ian Buysschaert (ORCID: https://orcid.org/0000-0003-1754-9334)
- David Zach (ORCID: https://orcid.org/0000-0003-0815-6731)
- Mathias Claeys (ORCID: https://orcid.org/0000-0002-3998-5340)
- Nicolas Verheyen (ORCID: https://orcid.org/0000-0001-7414-4056)
- R. Van Hoeyweghen
- Milad El Haddad (ORCID: https://orcid.org/0000-0001-9436-7820)
- L Buytaert (ORCID: https://orcid.org/0009-0008-2795-4388)
- Annemie Jacobs (ORCID: https://orcid.org/0000-0002-2094-8128)
- Karl Dujardin
- Nicolas Wyseure
Institutions
- Cliniques Universitaires Saint-Luc (BE)
- Delta Air Lines (United States) (US)
- Vrije Universiteit Brussel (BE)
- Medical University of Graz (AT)
- AZ Sint-Jan (BE)
- Universitair Ziekenhuis Brussel (BE)
- AZ Delta (BE)
- Hasselt University (BE)
- KU Leuven (BE)
Publication Details
- Journal
- European Heart Journal
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1093/eurheartj/ehae923
- Citations
- 23
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 17.73
Funders
- Bristol-Myers Squibb
- Pfizer
- Boehringer Ingelheim España
- Swedish Orphan Biovitrum
- Bristol-Myers Squibb Canada